samedan logo
 
 
spacer
home > pmps > summer 2021 > building fit-for-purpose life science infrastructure
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Building Fit-for-Purpose Life Science Infrastructure

The life science and diagnostics industries have never been so vital to health outcomes, both domestically and abroad. Testing, diagnostics, and manufacturing capabilities have been pushed to the limit during the COVID-19 pandemic and the global effort to identify positive cases, find new treatments, and roll out vaccinations against the novel virus en masse.

Having left the emergency phase of the pandemic behind in the UK, it is an important opportunity to review and debate the future of our domestic pharma manufacturing infrastructure – including cleanrooms and sterilisation facilities.

Bolstering the UK’s Competitive Edge

Now the focus is to put the UK at the forefront of the life science and diagnostics industries and maintain a world-leading position for years to come, post-COVID-19. However, to continue to excel and lead the way in global scientific advancement, the UK must build on its cleanroom and sterilisation capabilities to create superior pharmaceutical products when it comes to quality, safety, and compliance.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rich Quelch, Global Head of Marketing at Origin, is an experienced global marketer within the healthcare and pharma sector. He has led the development of the Origin brand, positioning it as a world-leading supplier of innovative and groundbreaking pharma packaging devices, as well as offering a unique supply chain model, which is disrupting the pharma industry.
spacer
Rich Quelch
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SGS QUAY PHARMA RECEIVES QUEEN’S AWARD FOR INDUSTRY

Leading pharmaceutical contract development and manufacturing organisation (CDMO) SGS Quay Pharma has received its Queen’s Award for Enterprise. The award was presented by the Lord Lieutenant of Clwyd, Henry Fetherstonhaugh, OBE, in a special ceremony at the company’s global headquarters in Deeside Industrial Park, Flintshire.
More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement